The European Medicines Agency (EMA) has begun its relocation. Its management board gave approval on Wednesday 28 February to the revised offer from the Dutch authorities on its new premises. The EMA has, consequently, sent notification to the EU’s Budgetary Authority of its intention to move.
The Dutch offer, which won the approval of the member states in November of last year (see EUROPE 11908), was based on a phased relocation, firstly to temporary premises and then to custom-built...